Dexamethasone in Preventing Post Dural Puncture Headache
Saad Khizer, Madiha Zafar, Varda Balouch, Mubashar Iqbal, Rooshaan Kaleem, Shahid adalat Chaudhry
870
ABSTRACT
Background and Aim: Post-dural puncture headache is major
complication of spinal anesthesia that occurs in 40% of cases. Invasive
treatment like an epidural blood patch might be required for post-dural
puncture headache. The Dexamethasone effect on Post-Dural Puncture Headache
following spinal anesthesia is not addressed and well understood. The aim of
the present study was to assess the role of Dexamethasone in post-dural
puncture headaches.
Materials and Methods: This cross-sectional study was carried
out on 456 patients who underwent spinal anesthesia from 16th April
2021 to 15th October 2021 at the department of Anesthesiology of Pakistan
Ordnance Factories (POF)Hospital,WahCantt, Mayo Hospital, Lahore andMohi-ud-Din
Teaching Hospital, Mirpur AJK. All the patients who underwent spinal anesthesia
were enrolled whereas patients with previous headache disorder and
contraindicated for steroids were excluded. Patients were allocated to two
groups; Group A (Placebo) and Group B (Dexamethasone). Placebo group patients
were injected with normal saline (2 mL) and other group patients with
dexamethasone prophylactic epidural injection (2 mL, 8 mg). The incidence and
severity of post-dural puncture headache and backache at the puncture site were
evaluated on the 1st, 3rd, and 7th
postoperative days. SPSS version 24 was used for data descriptive analysis.
Results: A total of 456 patients underwent spinal
anesthesia in which 228 patients over age of 20 years were assigned to each
group. The prevalence of post-dural puncture headache was found lower in
dexamethasone group patients 14 (6.2%) compared to normal saline 26 (11.6%) on
the post-operative first day (p<0.05). However, on days 3 and 7, the
difference disappeared. The overall prevalence of post-dural puncture headache
was 21 (9.4%) in the dexamethasone group and 11 (4.7%) in the placebo group,
which is statistically insignificant (p-value=0.132). There was no statistical
significance in terms of headache severity (2.7% in the study group versus 7%
controls group; p-value =0.128). The incidence of symptoms like vomiting or
nausea occurred in a lower number of dexamethasone group patients compared to
placebo. The prevalence of backache between the two groups was found
insignificant.
Conclusion: Our study found that the prevalence of
post-dural puncture headache was lower in dexamethasone group patients but
improved with increasing post-operative days and extended to the placebo group.
Our findings contradict the earlier studies in regard to dexamethasone's
effectiveness in post-dural puncture headache treatment. Based on our findings,
dexamethasone cannot be recommended for post-dural puncture headaches.
Keywords: Post-Dural puncture headache; Dexamethasone;
Spinal Anesthesia
ABSTRACT
Background and Aim: Post-dural puncture headache is major
complication of spinal anesthesia that occurs in 40% of cases. Invasive
treatment like an epidural blood patch might be required for post-dural
puncture headache. The Dexamethasone effect on Post-Dural Puncture Headache
following spinal anesthesia is not addressed and well understood. The aim of
the present study was to assess the role of Dexamethasone in post-dural
puncture headaches.
Materials and Methods: This cross-sectional study was carried
out on 456 patients who underwent spinal anesthesia from 16th April
2021 to 15th October 2021 at the department of Anesthesiology of Pakistan
Ordnance Factories (POF)Hospital,WahCantt, Mayo Hospital, Lahore andMohi-ud-Din
Teaching Hospital, Mirpur AJK. All the patients who underwent spinal anesthesia
were enrolled whereas patients with previous headache disorder and
contraindicated for steroids were excluded. Patients were allocated to two
groups; Group A (Placebo) and Group B (Dexamethasone). Placebo group patients
were injected with normal saline (2 mL) and other group patients with
dexamethasone prophylactic epidural injection (2 mL, 8 mg). The incidence and
severity of post-dural puncture headache and backache at the puncture site were
evaluated on the 1st, 3rd, and 7th
postoperative days. SPSS version 24 was used for data descriptive analysis.
Results: A total of 456 patients underwent spinal
anesthesia in which 228 patients over age of 20 years were assigned to each
group. The prevalence of post-dural puncture headache was found lower in
dexamethasone group patients 14 (6.2%) compared to normal saline 26 (11.6%) on
the post-operative first day (p<0.05). However, on days 3 and 7, the
difference disappeared. The overall prevalence of post-dural puncture headache
was 21 (9.4%) in the dexamethasone group and 11 (4.7%) in the placebo group,
which is statistically insignificant (p-value=0.132). There was no statistical
significance in terms of headache severity (2.7% in the study group versus 7%
controls group; p-value =0.128). The incidence of symptoms like vomiting or
nausea occurred in a lower number of dexamethasone group patients compared to
placebo. The prevalence of backache between the two groups was found
insignificant.
Conclusion: Our study found that the prevalence of
post-dural puncture headache was lower in dexamethasone group patients but
improved with increasing post-operative days and extended to the placebo group.
Our findings contradict the earlier studies in regard to dexamethasone's
effectiveness in post-dural puncture headache treatment. Based on our findings,
dexamethasone cannot be recommended for post-dural puncture headaches.
Keywords: Post-Dural puncture headache; Dexamethasone;
Spinal Anesthesia